ZIOPHARM Oncology Inc. (ZIOP) could find an ally in its 200-day moving average ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is struggling today, despite a drug data win for the biotech stock. Earlier, ZIOP ...

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and ...

If you are looking for the best ideas for your portfolio you may want to consider some of Miller Value Partners top stock picks. Miller Value Partners, an investment management firm, is bullish on ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in NVIDIA Corp (Symbol: NVDA), where a total volume of 60,976 contracts has been ...

However I also observe that ZIOP has now had a full week to supplement and expand upon that very brief initial press release, but has not yet done so. Instead we received new and unrelated information ...

Ziopharm Oncology (ZIOP) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-. Editor’s Note: Any reference to TheStreet Ratings and its underlying recommendation does ...

Ziopharm Oncology (ZIOP) is expected to deliver a year-over-year increase in earnings on flat revenues when it reports results for the quarter ended September 2018. This widely-known consensus outlook ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ZIOPHARM Oncology Inc (NASD: ZIOP), where a total volume of 9,180 contracts has ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ZIOPHARM Oncology Inc (NASD: ZIOP), where a total of 13,731 contracts have traded so far, ...